Chinese State-Owned Funds Invest in Biotech Firm MabPlex
January 17, 2019 — 15:30 CST
This Data Is Locked!
This area is available only to Subscribers.
MabPlex International, a Chinese biologics development and manufacturing solutions provider, has completed a RMB400 million (US$59.1 million) series A round of financing. The round was... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals